Literature DB >> 9473512

B1 bradykinin receptors and carboxypeptidase M are both upregulated in the aorta of pigs after LPS infusion.

E Schremmer-Danninger1, A Offner, M Siebeck, A A Roscher.   

Abstract

Bradykinin receptor subtypes were characterized in aortic cryosections obtained from healthy normal pigs, animals that were given an LPS infusion, and animals that came with a pre-existing infection or inflammation to the laboratory by binding studies and in vitro autoradiography. In control aorta a single class of high affinity B2 binding sites, located within the endothelium, but with no significant binding of B1 ligand were identified. No major changes in the expression of B2 BK receptors were noted in inflammed tissues. In cryosections of inflammed vascular tissue a markedly increased endothelial carboxypeptidase M activity was verified that parallelled an upregulation of B1 receptors in the aortic smooth muscle layer. In crosstalk between endothelial cells and smooth muscle cells B1 receptor mediated functional responses may counteract some of the detrimental effects of inflammation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473512     DOI: 10.1006/bbrc.1997.7999

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Increased susceptibility to endotoxic shock in transgenic rats with endothelial overexpression of kinin B(1) receptors.

Authors:  Vanessa F Merino; Mihail Todiras; Luciana A Campos; Vera Saul; Elena Popova; Ovidiu C Baltatu; João B Pesquero; Michael Bader
Journal:  J Mol Med (Berl)       Date:  2008-04-19       Impact factor: 4.599

2.  Endothelium-Neutrophil Communication via B1-Kinin Receptor-Bearing Microvesicles in Vasculitis.

Authors:  Pierre-Louis Tharaux; Neeraj Dhaun
Journal:  J Am Soc Nephrol       Date:  2017-07-14       Impact factor: 10.121

3.  Vascular kinin B(1) and B(2) receptor-mediated effects in the rat isolated perfused kidney - differential regulations.

Authors:  K Bagaté; L Develioglu; J L Imbs; B Michel; J J Helwig; M Barthelmebs
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

Review 4.  Contact system activation in severe infectious diseases.

Authors:  Sonja Oehmcke; Heiko Herwald
Journal:  J Mol Med (Berl)       Date:  2010-02       Impact factor: 4.599

5.  Cross-talk between carboxypeptidase M and the kinin B1 receptor mediates a new mode of G protein-coupled receptor signaling.

Authors:  Xianming Zhang; Fulong Tan; Viktor Brovkovych; Yongkang Zhang; Randal A Skidgel
Journal:  J Biol Chem       Date:  2011-03-31       Impact factor: 5.157

6.  Predictive value of serum bradykinin and desArg9-bradykinin levels for chemotherapeutic responses in active tuberculosis patients: A retrospective case series.

Authors:  Xu Qian; Duc T M Nguyen; Yaojun Li; Jianxin Lyu; Edward A Graviss; Tony Y Hu
Journal:  Tuberculosis (Edinb)       Date:  2016-09-28       Impact factor: 3.131

7.  A novel inflammatory pathway involved in leukocyte recruitment: role for the kinin B1 receptor and the chemokine CXCL5.

Authors:  Johan Duchene; Florence Lecomte; Saleh Ahmed; Cecile Cayla; Joao Pesquero; Michael Bader; Mauro Perretti; Amrita Ahluwalia
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

8.  Implication of the bradykinin receptors in antigen-induced pulmonary inflammation in mice.

Authors:  Jadranka Eric; Bichoy H Gabra; Pierre Sirois
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

9.  Carboxypeptidase M is a positive allosteric modulator of the kinin B1 receptor.

Authors:  Xianming Zhang; Fulong Tan; Randal A Skidgel
Journal:  J Biol Chem       Date:  2013-10-09       Impact factor: 5.157

10.  The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers.

Authors:  Parker C Wilson; Mi-Hye Lee; Kathryn M Appleton; Hesham M El-Shewy; Thomas A Morinelli; Yuri K Peterson; Louis M Luttrell; Ayad A Jaffa
Journal:  J Biol Chem       Date:  2013-05-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.